
Daniel Goldstein MD
1.8K posts

Daniel Goldstein MD
@drdgoldstein
Founding Director, Center for Cancer Economics, Professor of Oncology @Rabinmedical_. @TelAvivUni.





Honoured to be standing for @uicc Board of Directors. Fewer cancers, better survival, fairer access to care through collaboration and partnership, is why I am standing. See my FB post for more info: facebook.com/share/p/eEXU3N… #UICC #CancerEquity #BetterFairerCancerCare

📣 Choosing Wisely in oncology: are guidelines effective at preventing unnecessary diagnostics? The example of surveillance positron emission tomography for patients with localised colorectal cancer Check out this #originalresearch from @drdgoldstein and colleagues: bmjoncology.bmj.com/content/3/1/e0… #oncoalert @oncoalert

Thanks @drdgoldstein for coming all the way from 🇮🇱 to 🇭🇰 to share insights and experiences in #pharmacoeconomics. Organised by #ProfVivianLee and colleagues of @cuhkpharmacy Very engaged workshop together with stakeholders from #academia, #industry, #patientsrepresentatives and the #HospitalAuthority @CUHKMedicine @hkumed




NEWS: I sent a letter to Amgen to investigate the pharma co’s decisions on its cancer drug—after FDA review & new studies suggest its dosing level may be excessive, exposing cancer patients to unnecessarily high costs & harsh side effects from the company’s 8-pill daily dosage.

Totally flattered by all who tagged me when they shared this piece. As @VPrasadMDMPH said, I wish I had written it.

Common Sense Oncology leadership team is having its first annual meeting next week in Montreal. Our opening plenary session will be open to all CSO members. Join us by zoom for the LIVE plenary session with these leaders in our field. Register for zoom link here- zoom.us/webinar/regist…








A new review suggests that many cancer drugs are interchangeable, which could potentially lead to significant cost savings for patients and health systems. @drdgoldstein bmjoncology.bmj.com/content/3/1/e0…


